Clinical Trial Update: Phase IV, a Clinical Trial to Assess Safety and Convenience of the Change From DTG/3TC to BIC/FTC/TAF in People With HIV, Good Virological Control and Neuropsychiatric Vulnerabilities [Phase 4]

View source ↗

Summary

Phase IV trial assessing safety and convenience of switching virologically controlled people with HIV from dolutegravir/lamivudine to bictegravir/emtricitabine/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• BIKTARVY (BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE)
• Dovato (dolutegravir/lamivudine)

Snippet

Sponsor: Fundacion SEIMC-GESIDA | Conditions: HIV Infections | Phase 4 | Status: COMPLETED